Results 241 to 250 of about 477,437 (308)
GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?
The Laryngoscope, EarlyView.
Alina Zgardau +3 more
wiley +1 more source
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
What Are the Impacts of GLP‐1 Drugs in Patients Needing Head/Neck Surgery?
The Laryngoscope, EarlyView.
Chelsea Gelboin‐Burkhart +3 more
wiley +1 more source
Role of Acid‐Sensing Ion Channels 1a in the Regulation of Obesity and the Gut Microbiota
ABSTRACT Objective Acid‐sensing ion channels are proton‐activated ion channels predominantly found in the nervous system. They are well known to affect metabolic and neurological health, yet their role in obesity and gut physiology remains unclear. This study investigates how systemic deletion of Asic1a influences obesity, metabolic, and gut‐based ...
Jane Shearer +7 more
wiley +1 more source
ABSTRACT Objective In this study, we investigated the effects of a stem cell‐derived secretome product on adiposity and tissue quality and insulin and glucose levels in obese mice and those undergoing dietary weight loss. Methods Following 16 weeks of high fat diet mice received acute (4 weeks) biweekly intramuscular injections with vehicle or ...
Zachary J. Fennel +11 more
wiley +1 more source
ABSTRACT The off‐label use of glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) among people without obesity and/or diabetes is rapidly expanding, despite a lack of clinical justification or safety data in this population. This Perspective explores the sociomedical dimensions of this trend, highlighting key research gaps and emerging hypotheses ...
Fernanda Baeza Scagliusi +5 more
wiley +1 more source
ABSTRACT Objective This study examined associations between CDC's 2022 extended BMI percentiles (BMIp) and cardiometabolic biomarkers. Methods Using electronic medical record data, we included patients aged 6–17 years with BMI ≥ 85th percentile who had at least one of the following: total cholesterol, low‐density lipoprotein cholesterol (LDL), high ...
Samantha L. Pierce +4 more
wiley +1 more source

